Selective uterine artery embolization is a valid adjuvant treatment of choriocarcinoma: a case report and literature review.

IF 3.5 3区医学 Q2 ONCOLOGY Frontiers in Oncology Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI:10.3389/fonc.2024.1479603

Yuying Chen, Tingting Sun, Linjing Yuan, Yucong Huang, Aligu Yusufu, Yang Zhang, Xiaoyan Zhang, Shasha He, Yufeng Ren, Shuzhong Yao, Guofen Yang

{"title":"Selective uterine artery embolization is a valid adjuvant treatment of choriocarcinoma: a case report and literature review.","authors":"Yuying Chen, Tingting Sun, Linjing Yuan, Yucong Huang, Aligu Yusufu, Yang Zhang, Xiaoyan Zhang, Shasha He, Yufeng Ren, Shuzhong Yao, Guofen Yang","doi":"10.3389/fonc.2024.1479603","DOIUrl":null,"url":null,"abstract":"Background: Cervical choriocarcinoma is an extremely rare malignancy that is often misdiagnosed due to its nonspecific symptoms, such as vaginal bleeding.Case report: A 39-year-old female presented to the emergency department of the First Affiliated Hospital of Sun Yat-sen University with vaginal bleeding and a serum β-human chorionic gonadotropin (β-HCG) level of 229,386 mIU/mL. Initially, she was misdiagnosed with cervical pregnancy and subsequently underwent selective uterine artery embolization and cervical mass excision. However, pathological examination revealed the diagnosis of cervical choriocarcinoma.Conclusion: This case highlights the propensity for misdiagnosis of cervical choriocarcinoma. Selective uterine artery embolization proves to be an efficient measure to manage hemorrhage and potentially avoid unnecessary hysterectomy.","PeriodicalId":12482,"journal":{"name":"Frontiers in Oncology","volume":"14 ","pages":"1479603"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11588632/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fonc.2024.1479603","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Cervical choriocarcinoma is an extremely rare malignancy that is often misdiagnosed due to its nonspecific symptoms, such as vaginal bleeding.

Case report: A 39-year-old female presented to the emergency department of the First Affiliated Hospital of Sun Yat-sen University with vaginal bleeding and a serum β-human chorionic gonadotropin (β-HCG) level of 229,386 mIU/mL. Initially, she was misdiagnosed with cervical pregnancy and subsequently underwent selective uterine artery embolization and cervical mass excision. However, pathological examination revealed the diagnosis of cervical choriocarcinoma.

Conclusion: This case highlights the propensity for misdiagnosis of cervical choriocarcinoma. Selective uterine artery embolization proves to be an efficient measure to manage hemorrhage and potentially avoid unnecessary hysterectomy.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

选择性子宫动脉栓塞是一种有效的绒毛膜癌辅助治疗方法：病例报告和文献综述。

背景：宫颈绒毛膜癌是一种极为罕见的恶性肿瘤：宫颈绒毛膜癌是一种极为罕见的恶性肿瘤，因其阴道出血等非特异性症状而经常被误诊：一名 39 岁女性因阴道出血和血清 β-人绒毛膜促性腺激素（β-HCG）水平达 229,386 mIU/mL，来到中山大学附属第一医院急诊科就诊。最初，她被误诊为宫颈妊娠，随后接受了选择性子宫动脉栓塞术和宫颈肿块切除术。然而，病理检查显示她被诊断为宫颈绒毛膜癌：结论：本病例凸显了宫颈绒毛膜癌的误诊倾向。事实证明，选择性子宫动脉栓塞术是处理大出血的有效措施，并有可能避免不必要的子宫切除术。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Frontiers in Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research

CiteScore

6.20

自引率

10.60%

发文量

6641

审稿时长

14 weeks

期刊介绍： Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.